Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
08 Nov 2024 |
AD01 |
Registered office address changed from 7th Floor 50 Broadway London SW1H 0DB United Kingdom to Organon Pharma (Uk) Limited Shotton Lane Cramlington NE23 3JU on 8 November 2024
|
|
|
07 Nov 2024 |
TM01 |
Termination of appointment of Lee Francis Moore as a director on 28 October 2024
|
|
|
07 Nov 2024 |
TM01 |
Termination of appointment of Caterina Musgrave Juer as a director on 28 October 2024
|
|
|
07 Nov 2024 |
TM02 |
Termination of appointment of Vistra Cosec Limited as a secretary on 28 October 2024
|
|
|
07 Nov 2024 |
AP03 |
Appointment of Mr John Albert Parsons as a secretary on 28 October 2024
|
|
|
07 Nov 2024 |
AP01 |
Appointment of Mr Joseph Ralph Laskowski as a director on 28 October 2024
|
|
|
07 Nov 2024 |
PSC02 |
Notification of Organon & Co. as a person with significant control on 28 October 2024
|
|
|
07 Nov 2024 |
PSC07 |
Cessation of Roivant Sciences Ltd. as a person with significant control on 28 October 2024
|
|
|
31 Oct 2024 |
MR04 |
Satisfaction of charge 103176570005 in full
|
|
|
25 Oct 2024 |
MR04 |
Satisfaction of charge 103176570001 in full
|
|
|
25 Oct 2024 |
MR04 |
Satisfaction of charge 103176570002 in full
|
|
|
25 Oct 2024 |
MR04 |
Satisfaction of charge 103176570003 in full
|
|
|
25 Oct 2024 |
MR04 |
Satisfaction of charge 103176570004 in full
|
|
|
13 Aug 2024 |
CS01 |
Confirmation statement made on 8 August 2024 with no updates
|
|
|
23 Dec 2023 |
AA |
Full accounts made up to 31 March 2023
|
|
|
08 Aug 2023 |
CS01 |
Confirmation statement made on 8 August 2023 with updates
|
|
|
08 May 2023 |
TM01 |
Termination of appointment of Martin William Gordon Palmer as a director on 26 April 2023
|
|
|
08 May 2023 |
AP01 |
Appointment of Ms Caterina Musgrave Juer as a director on 26 April 2023
|
|
|
13 Apr 2023 |
SH01 |
Statement of capital following an allotment of shares on 30 March 2023
|
|
|
16 Dec 2022 |
AA |
Full accounts made up to 31 March 2022
|
|
|
12 Oct 2022 |
AD01 |
Registered office address changed from Suite 1, 3rd Floor 11-12 st. James's Square London SW1Y 4LB United Kingdom to 7th Floor 50 Broadway London SW1H 0DB on 12 October 2022
|
|
|
17 Aug 2022 |
CS01 |
Confirmation statement made on 8 August 2022 with updates
|
|
|
22 Apr 2022 |
PSC09 |
Withdrawal of a person with significant control statement on 22 April 2022
|
|
|
22 Apr 2022 |
PSC02 |
Notification of Roivant Sciences Ltd. as a person with significant control on 1 October 2021
|
|
|
11 Apr 2022 |
SH01 |
Statement of capital following an allotment of shares on 29 March 2022
|
|